Francis Collins, a renowned geneticist and former longtime director of the National Institutes of Health, has retired, leaving the US agency that's being upended by budget cuts and layoffs.

“When you hear about patients surviving stage 4 cancer because of immunotherapy, that was based on NIH research over many decades. When you hear about sickle cell disease being cured because of ...

EIK1001 was initially developed by Seven and Eight Biopharmaceuticals. Eikon licensed global rights to that immunotherapy and another TLR7/8 agonist in 2023; financial terms were not disclosed.

Aplastic anaemia is a rare but serious blood disorder in which the bone marrow fails to produce enough blood cells—red blood cells, white blood cells, and platelets. This condition can lead to ...

Both are untreatable hereditary diseases. Some of the research involves using probiotics and cockroach allergy immunotherapy to potentially reduce development of asthma. One finding of such research ...

1Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

24, 2025 (GLOBE NEWSWIRE) -- Gylden Pharma Limited ('Gylden' or the 'Company'), a clinical-stage biotechnology company that is addressing major global infectious diseases through the development of ...

What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder cancer? Why do only 20% of advanced bladder cancer cases respond to immunotherapy?

Department of Surgery, Division of Surgical Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, United States Center for Systems Immunology, University of Pittsburgh, Pittsburgh, ...

Supported by Swim Across America, the Simon and Eve Colin Foundation, the Dalton Family Foundation, the American Association for Cancer Research–Stand Up To Cancer Colorectal Cancer Dream Team ...